drugresist superb pose huge threat human health infect enterobacteriacea product metalβlactamas mbl eg new delhi metalβlactamas nd difficult treat develop effect mbl inhibitor revid efficacy exist antibiotic highly desire howe clinic avail till show antihelicobact pylons drug collide bismuth submit cb relay iii compound irrevers inhibit differ type via meghan one display two nii ion reveal gray crystallography lead release cofactor restore meropenem mer mblposit bacteria vitro mouse infect model importantly also slow higherlevel resist deposit studi demons high potent first broadspectrum b bacteria conduct carbapenem 